Compare GNSS & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GNSS | NRXS |
|---|---|---|
| Founded | 1992 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | |
| Sector | Consumer Staples | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 77.0M | 78.9M |
| IPO Year | 1996 | 2023 |
| Metric | GNSS | NRXS |
|---|---|---|
| Price | $1.32 | $6.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $3.87 | ★ $11.00 |
| AVG Volume (30 Days) | 66.4K | ★ 134.9K |
| Earning Date | 08-13-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 44.44 | 22.13 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $26,306,790.00 | $3,569,282.00 |
| Revenue This Year | $39.82 | $132.54 |
| Revenue Next Year | $12.95 | $138.55 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 29.50 | ★ 32.89 |
| 52 Week Low | $1.31 | $2.21 |
| 52 Week High | $2.47 | $9.33 |
| Indicator | GNSS | NRXS |
|---|---|---|
| Relative Strength Index (RSI) | 28.75 | 42.51 |
| Support Level | N/A | $5.52 |
| Resistance Level | $1.60 | $7.75 |
| Average True Range (ATR) | 0.07 | 0.48 |
| MACD | -0.01 | -0.11 |
| Stochastic Oscillator | 2.13 | 3.33 |
Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).